Vascularization represents a pivotal frontier in organoid technology, essential for overcoming the critical size limitation, preventing necrotic cores, and achieving physiological relevance for accurate disease modeling and drug screening.
Induced pluripotent stem cells (iPSCs) offer unprecedented potential for disease modeling, drug screening, and regenerative medicine.
This article addresses the critical challenge of variability in induced pluripotent stem cell (iPSC) differentiation, a major hurdle in research and drug development.
The generation of induced pluripotent stem cells (iPSCs) free of integrated transgenes is a critical step toward their safe clinical application in regenerative medicine and drug development.
The efficient generation of mature, functional neurons from human induced pluripotent stem cells (iPSCs) is critical for advancing disease modeling and drug screening.
This article provides a comprehensive guide for researchers and drug development professionals on the latest strategies to enhance the efficiency and safety of induced pluripotent stem cell (iPSC) generation.
This article provides a comprehensive guide for researchers and drug development professionals on managing genomic instability in induced pluripotent stem cells (iPSCs) during extended culture.
Spontaneous differentiation remains a significant challenge in induced pluripotent stem cell (iPSC) culture, compromising experimental reproducibility and the efficacy of cell therapies.
This article provides a comprehensive comparison of Matrigel and laminin coatings for induced pluripotent stem cell (iPSC) culture, tailored for researchers and drug development professionals.
Sendai virus (SeV) vector technology has emerged as a leading method for generating induced pluripotent stem cells (iPSCs) without genomic integration, a critical safety consideration for clinical applications.